Columbia University shifted policies in an effort to restore federal funding and so far hasn't seen much in return. Meanwhile ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.